A Combined Digital and Biomarker Diagnostic Aid for Mood Disorders (the Delta Trial): Protocol for an Observational Study

Olmert T., Cooper J. D., Han S. Y. S., Barton-Owen G., Farrag L., Bell E., ...Daha Fazla

JMIR RESEARCH PROTOCOLS, cilt.9, sa.8, 2020 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 9 Sayı: 8
  • Basım Tarihi: 2020
  • Doi Numarası: 10.2196/18453
  • Dergi Adı: JMIR RESEARCH PROTOCOLS
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Directory of Open Access Journals
  • Anahtar Kelimeler: proteomics, early diagnosis, mood disorders, bipolar disorder, major depressive disorders, BIPOLAR-II-DISORDER, CLINICAL-TRIALS, MENTAL-DISORDERS, EFFICACY TRIALS, DEPRESSION, PREVALENCE, GENERALIZABILITY, BURDEN, FRAMEWORK, IMPACT
  • Orta Doğu Teknik Üniversitesi Adresli: Evet

Özet

Background: Mood disorders affect hundreds of millions of people worldwide, imposing a substantial medical and economic burden. Existing diagnostic methods for mood disorders often result in a delay until accurate diagnosis, exacerbating the challenges of these disorders. Advances in digital tools for psychiatry and understanding the biological basis of mood disorders offer the potential for novel diagnostic methods that facilitate early and accurate diagnosis of patients.